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teaching process occurrences of non-compliance, lnisnnder- 
standing and miscommunication can still occur. We will also 
show different ways staff evaluates medication administration 
and compliance. 
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A REVIEW OF DONOR LYMPHOCYTE INFUSIONS USED IN NON-MYE- 
LOABLATIVE, T-CELL DEPLETED, ALLOGENEIC STEM CELL TRANS- 
PLANTS IN ADULTS 
Thompson, k/l., Rizzieri, D.; Cat~in, C.; BurlesoJz, J.; EreT1, 34.; k~lje- 
rich, D. Adult BoJTe Marrow TrmTsplm~t, Duke Universit), ~ledical 
Ceute*; Dm't, am, NC. 
Allogeneic stem cell transplantation has been the cornerstone in 
long-term survival for many hematologic malignancies. Unfortu- 
nately, the myeloablative chemotherapy regimens can often be too 
rigorous for some patients. Non-myeloablative allogeneic stem 
cell transplantation is a relatively new concept in cancer treatment 
that can offer a potential benefit with less toxicity to patients who 
would not otherwise qualify for myeloablative treatment. The 
non-myeloablative preparative regimen is less toxic to the patient 
who can then benefit from the graft versus malignancy effect that 
the allogeneic stem cells can provide. Donor lymphocyte infilsions 
(DLI) are often given after t ansplantation to boost donor engraft- 
ment or to treat residual disease but can be associated with an 
increased risk of graft versus host disease. *When dosed correctly 
and at the appropriate time following the transplant, DLIs can be 
crucial in achieving 100% donor engraftment with minimal risk. 
This poster will review DLI dosages and associated toxicities in 37 
adult patients in a clinical trial using a non-myeloablative prepara- 
tive regimen followed by allogeneic transplant and post transplant 
DLIs. Developing a standard for dosing and transfusing DLls 
with minimal risk provides a unique challenge to our entire health 
care team and is an area that needs further esearch. 
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FUTURE FUNGAL FIGHTERS 
Rivera, Z.R. Blood aJz{l Marrow Tra*l~plmztation, MD Amlerso*7 
Cm~cer Celeter, Hozlstom TX; MD AT~derson Cnncer Cellte~; Hous- 
toTz, %k2 
Blood and Marrow Transplantation (BMT) patients are very 
susceptible to infections particularly of a fungal source. Invasive 
fimgal infections carry a high morbidity and mortality rate. Clini- 
cians are now taking a new approach to treat fungal infections due 
to recurrence, occurrence of resistant infections, aud increasing 
risk factors of transnfission of infection in susceptible hosts espe 
cially those patients with hematological disease or ou innnunosup- 
presive therapy. Most common fungal pathogens are of the Candi 
da species and Aspergillns pecies. Antifungal treamaent is given 
prior to and post BMT. Traditional treatment of choice to pre- 
vent fungal infection in BMT recipients is Fluconazole or Itra- 
conazole. In the treatment of fungal infection, the chosen thera- 
peutic option is Aurphotericin B or its lipid formation. The 
response to the current antifungal medications varies in patients. 
Monitoring of adverse reactions uch as chills, fever, and anaphy- 
laxis is also a priority; therefore premedications are necessary prior 
to the administration of Amphotericin B. Due to the effects these 
agents have on kidney and liver function, dosing of the medica- 
tions is critical. Despite the current treatments, resistant infections 
are beconaing a serious problem. In r~sponse to the problem of 
resistant fimgal infections: combination therapy or newer agents 
like Voriconazole and Caspofungin arc being used. Voriconazole 
and Caspofungin are less toxic on the kidneys and liver, premed- 
ications are not required, and thus better tolerated by BMT 
patients. A case study will be presented including prophylactic 
naanagelnent aswell as treatment of a BMT patient with fnngal 
infection. Continued research is being done to determine the best 
uses of these agents ahme or in combination therapy in order to 
better treat fungal infections in our BMT patients and decrease 
toxicities. 
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THE COMPLEXITY OF TRANSITIONING BLOOD AND MARROW 
PATIENTS FROM OUTPATIENT TO INPATIENT 
Cala'mm'a, J.M.; Stray, S.; Nemnam~, J.; Adorlletto, D.; Jolmstom P. 
~ID AmlersoTz Cm2cer Ce~zte~; Houstol~, TX. 
Transitioning the blood and marrow transplant patient from the 
outpatient clinic to the inpatient setting in a large comprehensive 
cancer center, perforuaing over 550 transplants a year, can be a 
challenging and complex process. During a collaborative review of 
this process, it was decided to focus on the admission procedure 
bem~een these areas to assure seamless commnnieation. The goal 
of this process was to provide a more consistent method of com- 
nrunicating information regarding the admission of a patient. The 
transplant team members identified the solution to be the creation 
of a designated admission folder. This fBlder is started for each 
patient being admitted, along with a checldist of required con- 
tents. The checldist is a document in which the outpatient staff 
verifies that the required contents are present in the folder. The 
checklist includes pre-transplant worknp, chemotherapy orders, 
height and weight, psychosocial ssessment by the social workers, 
copy of patient's blood and informed consent, patient's treatment 
plan and flowsheet including a complete disease history. The 
checklist is the key communication tool for staff and must be com- 
pleted before the patient leaves the clinic to be admitted. The 
checklist is completed on the day of admission, and contents of 
the folder reviewed by the transplant physician. The pharmacist 
also uses the iuformation in the folder to assist with writing the 
chemotherapy orders. The clinic nurse completes the checldist 
adding any comments or updates. The folder and checklist is then 
sent to the inpatient unit along with the patient naedicaI record. 
The beuefit o the inpatient unit is that all revelant docmnents are 
organized and placed in a designated folder, thereby, expiditing 
order transcription and the general admission process. At the 
present time, the folder acts as a transition for the electronic med 
ical records system, currently in the developmental stage. This 
folder and checklist creates a standard practice regarding the 
admission process in the Blood and Marrow Transplant clinic for 
the mulitdisiplinary team. A tool is being developed to audit the 
effectiveness of this new process. 
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TREATMENT PLANS FOR BLOOD AND MARROW TRANSPLANTATION 
PATIENTS; THE COMMUNICATION LINK 
Stray, &ft.; Willidms, P.A.; Crzls, E.; Graves, L.; Adornetto, D.L.; 
l,Valleet', J. B3dT CeJzter, UTMD Allde'rsom Houston7, TX. 
Transitioning patients through the Blood and Marrow Trans- 
plant (BMT) process requires seamless comnmnication amongst 
various healthcare team members and clinical areas. The treat- 
ment plan is a documentation tool that details the treatment pro- 
tocol and cell infusion for the transplant and serves as the commu- 
nication link between team uaembers in the inpatient and 
outpatient clinical areas. Initially, the treatment plan was imple- 
mented as a tool to communicate the patients transplant therapy 
to thc insurance company and the BMT clinical pharmacist. How- 
ever, it has evolved into the main treatment connnunication tool 
amongst the multidisciplinary teams. Through its evolution the 
need became apparent to standardize the form, establish accounta- 
bility for the team melnbers, and develop a policy and procedure. 
A nmltidisciplinary task tbrce was formed to discuss the current 
process, the purpose of the form, and the concerns related to 
patient safety in the administration of the correct therapy. This 
task force, evaluated the process flow, established policy and pro- 
cedure, standardized the form, and reverified the content of cur- 
rent treatment plans being utilized. Further development of this 
prqcess will include the accessibility of the treatment plans in a 
central repository of the BMT database. This repository will allow 
read and print capabilities to any team member and the ability of 
designated team members to monitor and maintain the repository. 
As a result of this process, treatment plans are utilized as the com- 
munication link to ensure the patients plan of care is clear, accu 
rate, documented, and approved by the attending physician. Also, 
this tool provides conmmnication to all caregivers in the inpatient 
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and outpatient care areas while providing continuity of care and 
patient safety. 
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PENNY WISE BUT POUND FOOLISH: DO COST REDUCTION INIATIVES 
REALLY WORK IN THE PEDIATRIC STEM CELL TRANSPLANT POPU- 
LATION? 
F'J'ey, M.A. DHtee LT11iw"l'siO~ Pediatric Stem Cell Tl"allsplmlt Pvogvzrm, 
DzH'ham, NC. 
An unstable conomy and increasing payer demands have forced 
many health care providers to dramatically tighten their fiscal 
belts. The child undergoing a stem cell transplant is often a high 
user of both human and material resources. The cost of caring for 
these patients often is astronomical. In an effort to better contain 
costs, payers and administrators are now demanding that new and 
innovative solutions be imlemented in order to maximize 
resources and keep costs down. The ultimate goal of these solu- 
tions is to ma~mize quality patient care while still making stem 
cell transplantation affordable. The Duke Pediatric Stem Cell 
Transplant Unit is no exception. Our program has successfully 
implemented several initiatives that have reduced our cost per case 
as well as our length of stay. The purpose of this abstract is to 
identify and outline some of these cost containment initiatives. 
Some of these include, but are not limited to: 1. An approval 
process for high-cost pharmaceuticals (i.e liposomal drugs) 2. 
Reduction in the use of MG 3. The use of PYXIS for materials 
and supplies 4. A Retention/Recruitment Model for nursing. The 
cost of replacing a PSCT nurse exceeds $60, 000 5. An outpatient 
treatment facility which has resulted in a dramatic reduction in 
inpatient LOS 6. Expansion of the PSCT program to less acute 
venues of care The cost effectiveness and overall success of these 
initiatives will be outlined. The impact of these changes on patient 
satisfaction and staff will also be described. Our goal is to provide 
the highest possible level of patient care that includes a strong 
commitment to keeping costs contained. 
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A PARENT SUPPORT PROGRAM FOR CHILDREN UNDERGOING STEM 
CELL TRANSPLANTION." THE DUKE UNIVERSITY PEDIATRIC STEM 
CELL PROGRAM MODEL 
Hzmgate, J.; Fvey, M.A. D'ake UHiversity Pediat~'ic Stem Cell TvaTz.r- 
pla'~et Program, Dzlvham, NC. 
The care of the child undergoing a stem cell transplant requires 
a complex, multidisciplinary team approach in order to achieve 
the best possible outcome. Critical to the success of this approach 
is the role of the parent or caregiver. The road through transplant 
is often grueling. Parents typically stay with their children for the 
duration of therapy. Caregiver stress and burnout is a common 
phenomenon. Financial hardship often adds to the strain and wor- 
ries. Parental/Caregiver support is one element that is often over 
looked in the literature. The Duke Pediatric Stem Cell Transplant 
Program has implemented a family support program to cultivate a
formal relationship between the parent and the health care team. 
Core components of this program include: I. Pre-admission 
teaching and education related to parental expectations 2. The 
development of "The Duke PSCT Parent Handbook" which 
includes detailed caregiver education. 3. The Duke PSCT "Best 
Buddies Program" which utilizes carefully selected volunteers that 
support he family and allows the parent o leave the unit for brief 
periods of time. 4. A family resource area/lounge on the inpatient 
unit that provides cooking, bathing, and laundry fiacilities for care- 
givers. 5. The Fountain Fund Project which utilizes monies 
obtained from the Hospital iobby fountain for parent support 
projects. 6. The use of community volunteers such as hair stylists, 
food vendors, and other support which reduces emontional stress 
and can minimize extraneous expenses such as food and parking. 
7. Numerous fund raising activities (i.e. Racing Heroes Auction 
and Rainbow of Heroes Walk) which is a discretionary fund used 
to support parents and caregivers. 8. YVeekly psychosocial rounds 
which identify caregivers and family dynamics that may be high 
risk. The goal of this abstract is to illustrate the unique programs 
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used at Duke to support families and caregivers. The implementa- 
tion of these programs has resulted in high satisfaction scores as 
well as an indirect reduction in length of stay. 
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A NURSE IS NOT A NURSE! HOW TO RECRUIT AND RETAIN TOP 
NURSING TALENT IN PEDIATRIC STEM CELL TRANSPLANTATION 
Talbevt, G.; FT"e~,, M.A. DHke U~Ji-c,e1"si 9, 3/lecLi~l Ce~zteT", DzHqmm, NC. 
The recruitment and retention of top nursing talent is a major 
challenge for nurse managers. A sustained, profound national 
nursing shortage has dramatically altered the staffing patterns of 
academic medical centers. Nurses now have the opportunity to 
work in less acute settings with decreased stress at a higher rate of 
pay. Nursing travel companies often lure top recruits away from 
large teaching hospitals with agreements o pay a higher rate of 
pay as well as a housing stipend. Children undergoing marrow and 
stem cell transplantation require a nursing workforce that is highly 
specialized. The Foundation for the Accreditation of Cellular 
Therapy (FACT) mandates "that nurses and nursing supervisors 
be formally trained and experienced in the management of 
patients receiving hematopoietic progenitor cell transplants". The 
recruitment and retention of such a workforce requires a unique 
approach. "]'he purpose of this abstract is to identify barriers to the 
retention and recruitment of top nursing talent in this field. Con- 
tributing factors include a national nursing shortage and aging 
work force which have dramatically reduced the available pool of 
nurses. The major focus of this presentation will be to identify 
strategies to recruit and retain top nursing talent. These strategies 
include the development of a program entitled "Recruiting Talent 
and Rewarding Excellence in Pediatric Stem Ceil Transplant 
Nursing". Low" Cost /No  Cost initiatives will be discussed. The 
implementation f this program has been ovelwvhelmingly success- 
ful. There is currently awaiting list of new and experienced nurses 
hoping to have the priviledge to work in our program. Nursing 
turnover ates have dramatically declined. Overall staff" satisfaction 
has improved while patient quality indicators remain high. 
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DISCHARGE PLANNING CAN MAKE THE DIFFERENCE: THE DUKE PEDI- 
ATRIC STEM CELL TRANSLANT ACCELERATED DISCHARGE MODEL 
Gm'gaJ~z/s, K.ff.; F'J'ey, 3/I.A. Dzdee Ur~iz,e~'sity Pediatt'ic Stem Cell 
Tl:a~zspla~Tt P1"ogvam, Din'ham, NC. 
Discharge planning for the child undergoing a stem cell trans- 
plant requires a coordinated, multidisciplinary approach. Few 
patients have discharge needs that are more complex and compli- 
cated. The Duke Pediatric Stem Cell Transplant (PSCT) Pro- 
gram coordinates the care of over 80 active transplants each year. 
Financial pressures and mounting scrutiny from payers has forced 
Duke and other health care organizations to carefully monitor 
costs and look for alternatives to high cost inpatient care. In I995 
the PSCT program at Duke opened a new inpatient unit. Integral 
to this unit was the addition of a Bone Marrow Outpatient Proce- 
dure room. This room was and is currently used to treat patients 
who require after hours care on an emergent or urgent basis. Con- 
current with the advent of health care reform can initiatives look- 
ing at the reduction of cost and length of stay in children with 
complex medical needs. At he top of the list was children under- 
going stem cell and marrow transplantation. The purposc of this 
abstract is to describe initiatives that are currently being used to 
accelerate discharge in the pediatric stem cell transplant patient. 
integral to these initiatives is the expansion of the outpatient 
treatment facility to include after hours care. The key concept 
behind early discharge was the ability to provide bid complex 
medication administration that the caregiver could not provide. 
Patients are carefully evaluated by the physician based on selected 
early discharge criteria. A discharge planner is consulted to assess 
the caregivers readiness and ability to participate in our early dis- 
charge program. This presentation will detail the goals and crite- 
ria for our early discharge program. Highlighted will be the pro- 
grams ability to move patients through the system in a relatively 
seamless fashion. A cost analysis will be reviewed which shows a 
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